May 2025
1. SHAPIRO ALB, Narongkiatikhun P, Choi YJ, Wilkening G, et al
   Altered brain function and structure in youth-onset type 2 diabetes.
   Eur J Endocrinol. 2025 May 8:lvaf098. doi: 10.1093.
   

   >> Share

   
   April 2025
2. ZHANG M, Ward J, Strawbridge RJ, Anderson JJ, et al
   Genetic predisposition to adiposity, and type 2 diabetes: the role of lifestyle and phenotypic adiposity.
   Eur J Endocrinol. 2025;192:549-557.
   

   >> Share

   
   
3. FEOLA T, De Alcubierre D, Puliani G, Cozzolino A, et al
   Circulating immune cell profile in patients with acromegaly: results from the PROMISE, a prospective clinical trial.
   Eur J Endocrinol. 2025;192:577-589.
   

   >> Share

   
   March 2025
4. GLINTBORG D, Moller JK, Rubin KH, Christensen LL, et al
   Autoimmune diseases in 3812 Danish transgender persons and 38 120 cisgender controls before and after transgender care: a register-based cohort study.
   Eur J Endocrinol. 2025;192:408-417.
   

   >> Share

   
   
5. MENSBERG P, Frandsen C, Carl CS, Espersen E, et al
   High-intensity interval training improves insulin sensitivity in individuals with prediabetes.
   Eur J Endocrinol. 2025;192:456-465.
   

   >> Share

   
   
6. STERGIANOS S, Everhov AH, Soderling J, Bergthorsdottir R, et al
   Income and work loss in patients with Addison's disease: a nationwide population-based study.
   Eur J Endocrinol. 2025;192:170-179.
   

   >> Share

   
   
7. GAMBINERI A, Rosa S, Pandurevic S, Cecchetti C, et al
   Evolution of cardiovascular risk factors and the risk for cardiovascular events in a Caucasian population with polycystic ovary syndrome.
   Eur J Endocrinol. 2025;192:210-219.
   

   >> Share

   
   February 2025
8. OLLILA MM, Hautakoski A, Arffman M, Morin-Papunen L, et al
   Diabetic complications in women with type 2 diabetes and polycystic ovary syndrome.
   Eur J Endocrinol. 2025 Feb 21:lvaf026. doi: 10.1093.
   

   >> Share

   
   December 2024
9. ROBLEDO KP, Marschner IC, Grossmann M, Handelsman DJ, et al
   Predicting Type 2 Diabetes and Testosterone Effects in high-risk Australian men: Development and external validation of a 2 year risk model.
   Eur J Endocrinol. 2024 Dec 25:lvae166. doi: 10.1093.
   

   >> Share

   
   October 2024
10. LUNDQVIST MH, Pereira MJ, Wiklund U, Hetty S, et al
    Autonomic nervous system responses to hypo- and hyperglycemia in type 2 diabetes and prediabetes.
    Eur J Endocrinol. 2024 Oct 26:lvae130. doi: 10.1093.
    

    >> Share

    
    July 2024
11. HANSEN LS, Gasbjerg LS, Bronden A, Dalsgaard NB, et al
    The role of glucagon-like peptide 1 in the postprandial effects of metformin in type 2 diabetes: a randomized crossover trial.
    Eur J Endocrinol. 2024 Jul 25:lvae095. doi: 10.1093.
    

    >> Share

    
    
12. FOUNTAS A, Coulden A, Fernandez-Garcia S, Tsermoulas G, et al
    Central diabetes insipidus (vasopressin deficiency) after surgery for pituitary tumours: A systematic review and meta-analysis.
    Eur J Endocrinol. 2024 Jul 12:lvae084. doi: 10.1093.
    

    >> Share

    
    
13. ONO M, Nagao M, Takeuchi H, Fukunaga E, et al
    HLA investigation in ICI-induced T1D and isolated ACTH deficiency including meta-analysis.
    Eur J Endocrinol. 2024;191:9-16.
    

    >> Share

    
    
14. GROSSMANN M, Anawalt BD, Yeap BB
    Testosterone therapy in older men: clinical implications of recent landmark trials.
    Eur J Endocrinol. 2024;191:R22-R31.
    

    >> Share

    
    June 2024
15. RIX I, Lund AB, Garvey LF, Hansen CP, et al
    Increased hepatic glucagon sensitivity in totally pancreatectomised patients.
    Eur J Endocrinol. 2024;190:446-457.
    

    >> Share

    
    April 2024
16. FUHRI SNETHLAGE CM, Meijnikman AS, Mak AL, Rampanelli E, et al
    Prevalence and predictive features of metabolic dysfunction-associated steatotic liver disease in type 1 diabetes.
    Eur J Endocrinol. 2024 Apr 29:lvae043. doi: 10.1093.
    

    >> Share

    
    March 2024
17. GETHER IM, Bahne E, Nerild HH, Rehfeld JF, et al
    Colesevelam has no acute effect on postprandial GLP-1 levels but abolishes gallbladder refilling.
    Eur J Endocrinol. 2024;190:314-326.
    

    >> Share

    
    
18. ATILA C, Beck J, Refardt J, Erlic Z, et al
    Psychopathological characteristics in patients with arginine vasopressin deficiency (central diabetes insipidus) and primary polydipsia compared to healthy controls.
    Eur J Endocrinol. 2024 Mar 29:lvae040. doi: 10.1093.
    

    >> Share

    
    
19. AHN HY, Lee J, Kang J, Lee EK, et al
    Increased risk of diabetes mellitus and hyperlipidemia in patients with differentiated thyroid cancer.
    Eur J Endocrinol. 2024;190:248-255.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share